Finch Therapeutics Group Inc. (FNCH) NASDAQ

$2.31 (0.48) (-17.35%)

Market Cap: $4.48M

As of 04/24/24 03:59 PM EDT. Market closed.

(FNCH)

Finch Therapeutics Group Inc. (FNCH)
NASDAQ

$2.31
(0.48) (-17.35%)

Market Cap: $4.48M

As of 04/24/24 03:59 PM EDT. Market closed.

Add to Portfolio

finch therapeutics is unlocking the therapeutic potential of the microbiome through our human-first discovery platform. we use machine learning algorithms to reverse engineer successful fecal transplantations and other clinical datasets, identifying the microbes that drive responses in patients. this human-centric discovery model leverages clinical data to focus our in-vitro and in-vivo efforts ... read more

COMPANY PROFILE
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
Full Time Employees
123
Address
.
PRICE CHART FOR FINCH THERAPEUTICS GROUP INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$2.52
Previous Close
$2.79
Days Range
$2.39 - $3.04
52 week range
$1.86 - $16.74
Volume
118,253
Avg. Volume (30 days)
91,041
Market Cap
$4.48M
Dividend Yield
-
P/E
(0.06)
Shares Outstanding
1,605,763
Open
$2.52
Previous Close
$2.79
Days Range
$2.39 - $3.04
52 week range
$1.86 - $16.74
Volume
118,253
Avg. Volume (30 days)
91,041
Market Cap
$4.48M
Dividend Yield
-
P/E
(0.06)
Shares Outstanding
1,605,763
FINANCIAL STATEMENTS FOR FINCH THERAPEUTICS GROUP INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR FINCH THERAPEUTICS GROUP INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
SMISEK JEFFERY ADirectorMar 28, 2024 Sale$2.576,64217,0700Mar 29, 2024, 04:15 PM
SMISEK JEFFERY ADirectorMar 28, 2024 Sale$2.611,6004,1766,512Mar 29, 2024, 04:15 PM
SMISEK JEFFERY ADirectorNov 22, 2023 Sale$3.641,4705,3516,642Nov 27, 2023, 04:54 PM
Graf Susan EDirectorJun 09, 2023 Buy$0.275,0101,3535,010Jun 09, 2023, 04:15 PM
Blaustein MarcChief Operating OfficerOct 21, 2022 Sale$1.393,6365,05432,614Oct 25, 2022, 04:31 PM
Vittiglio JosephChief Business & Legal OfficerOct 21, 2022 Sale$1.393,6365,05431,364Oct 25, 2022, 04:25 PM
Haft NicholasDirectorDec 20, 2021 Buy$10.1863,850649,9934,056,907Dec 22, 2021, 06:21 PM
SMISEK JEFFERY ADirectorMar 23, 2021 Buy$17.0088,2351,499,9951,694,541Mar 25, 2021, 06:08 PM
Haft NicholasDirectorMar 23, 2021 Buy$17.00882,35114,999,967882,351Mar 25, 2021, 06:05 PM
FERRANTE DOMENIC JDirectorMar 23, 2021 Buy$17.00102,9411,749,997636,195Mar 25, 2021, 06:04 PM
Crestovo Investor LLCDirectorMar 23, 2021 Buy$17.00735,29412,499,99812,641,441Mar 25, 2021, 06:01 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
SMISEK JEFFERY ADirector03/28/202417,070
SMISEK JEFFERY ADirector03/28/20244,176
SMISEK JEFFERY ADirector11/22/20235,351
Graf Susan EDirector06/09/20231,353
Blaustein MarcChief Operating Officer10/21/20225,054
Vittiglio JosephChief Business & Legal Officer10/21/20225,054
Haft NicholasDirector12/20/2021649,993
SMISEK JEFFERY ADirector03/23/20211,499,995
Haft NicholasDirector03/23/202114,999,967
FERRANTE DOMENIC JDirector03/23/20211,749,997
Crestovo Investor LLCDirector03/23/202112,499,998
Load More Insider Transactions
FUNDS WITH A POSITION IN FINCH THERAPEUTICS GROUP INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BAUPOST GROUP LLC/MA67,2960.0053%No changeValue
RENAISSANCE TECHNOLOGIES LLC11,7460.00007%NewOther
BLACKROCK INC.3410%No changeOther
CHANGE IN SHARES OUTSTANDING FOR FINCH THERAPEUTICS GROUP INC
STOCK BUYBACKS FOR FINCH THERAPEUTICS GROUP INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
0.04%
1Q
12/31/2023
06/30/2023
0.05%
2Q
12/31/2023
03/31/2023
0.17%
3Q
12/31/2023
12/31/2022
0.50%
4Q
12/31/2023
09/30/2022
0.92%
5Q
12/31/2023
06/30/2022
1.24%
6Q
12/31/2023
03/31/2022
1.35%
7Q
12/31/2023
12/31/2021
22.87%
8Q
12/31/2023
09/30/2021
1.52%
9Q
12/31/2023
06/30/2021
1.66%
10Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
0.04%
1Q
06/30/2023
0.05%
2Q
03/31/2023
0.17%
3Q
12/31/2022
0.50%
4Q
09/30/2022
0.92%
5Q
06/30/2022
1.24%
6Q
03/31/2022
1.35%
7Q
12/31/2021
22.87%
8Q
09/30/2021
1.52%
9Q
06/30/2021
1.66%
10Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR FINCH THERAPEUTICS GROUP INC
LOADING...